Get Started Free
Home›Healthcare›Stryker Corporation
Stryker Corporation logo
Stryker Corporation
Healthcare

Stryker Corporation Company Overview

Stryker Corporation logo

Stryker Corporation

● Active
Healthcare · Kalamazoo, MI · Est. 1941
HealthcareMedTechOrthopedicsSurgical RoboticsMedical Devices↗ Website
$148.0B
Valuation
$24.5B
Revenue
52k+
Employees
1941
Founded

Stryker is one of the world's leading medical technology companies, offering a broad portfolio of innovative products and services in orthopedics, medical and surgical equipment, and neurotechnology. The company serves surgeons, hospitals, and healthcare systems across 75 countries with products ranging from joint replacement implants and surgical robots to emergency medical equipment.

Recent Press
5 items
Press Release·2026-01-28
Stryker Tops $25B in Full-Year 2025 Revenue, Up 11.2%
Stryker Corporation reported full-year 2025 net sales of $25.12 billion, an 11.2% increase year-over-year, with Q4 net sales of $7.17 billion, and guided for 8.0%-9.5% organic sales growth in 2026.
Product Launch·2026-01-28
Stryker Launches Mako RPS Handheld Robotic System for Knee Surgery
Stryker announced the launch of Mako RPS, a handheld robotic system for total knee surgery, with the first successful cases completed in early 2026, expanding the Mako SmartRobotics platform beyond its traditional arm-based configuration.
Press Release·2025-12-15
Stryker Appoints Spencer Stiles as President and COO
Stryker named Spencer Stiles as President and Chief Operating Officer effective January 1, 2026, tasking him with leading global business strategy, operations, and an active mergers and acquisitions pipeline described as "very healthy."
Product Launch·2025-09-20
Stryker Launches Incompass Total Ankle System at AOFAS Annual Meeting
Stryker unveiled the Incompass Total Ankle System at the American Orthopaedic Foot & Ankle Society annual meeting in 2025, adding a next-generation total ankle replacement to its orthopedic reconstruction portfolio.
Acquisition·2025-09-15
Stryker Completes Acquisition of Inari Medical for VTE Clot Removal
Stryker completed the acquisition of Inari Medical, a company specializing in innovative venous thromboembolism (VTE) clot removal solutions, as part of $4.96 billion in total acquisitions spending in 2025.
Company History
10 milestones
Dr. Homer Stryker, an orthopedic surgeon at Kalamazoo, Michigan, founded the company to commercialize medical devices he invented to improve patient care, including turning frames and cast cutters.

Stryker Corporation Organization Structure & Team

Org Chart
52,000 employees · Click a leader to explore their team
40,780 across 12 departments
Chief Executive Officer
Kevin Lobo
Glenn Boehnlein — Departments
· 40780 people across 12 depts

Stryker Corporation Financials, Revenue & Market Share

Annual Revenue
$24.5B
+8% vs prior year
YoY Growth
+8%
From $17.1B to $24.5B
Revenue / Employee
$435K
Annual revenue per full-time employee
Revenue Growth
2021
2022
2023
2024
2025
$17.1B
$18.4B
$20.5B
$22.6B
$24.5B
Market Share
Orthopedic Robotic Surgery
20%
share
Stryker
20%
J&J MedTech
24%
Zimmer Biomet
14%
Smith+Nephew
9%
Medtronic
13%
$620B
TAM
$110B
SAM
$22.6B
SOM
Revenue Streams
Orthopaedics36%
MedSurg40%
Neurotechnology24%
Business Units
Orthopaedics and Spine36%
Designs and markets joint reconstruction implants (knee, hip, shoulder), trauma fixation systems (Pangea, T2 Nail), and spine products (Tritanium interbodies) through Stryker's orthopedic sales force and MAKO robotic platform.
MedSurg and Neurotechnology (MedSurg)40%
Provides surgical equipment, hospital patient handling systems, endoscopy products, emergency medical equipment, and Sage patient care items to hospital systems and EMS providers globally.
Neurotechnology and Spine24%
Serves neurovascular, spine, and vascular markets with products including Trevo thrombectomy devices, Surpass Evolve flow diverter, Inari FlowTriever, and a broad portfolio of spine fusion and motion preservation implants.

Stryker Corporation Internal Tools & Processes

Internal Tools
12 departments
Orthopaedics — Joint Reconstruction4200 people · 3 roles
Standards & Certifications
10 standards
Compliance frameworks, security audits, and quality certifications this company maintains.
Quality
ISO 13485:2016
Certified
Stryker's medical device manufacturing facilities globally maintain ISO 13485:2016 certification for quality management systems specific to medical devices, ensuring consistent design, manufacturing, and post-market surveillance for orthopedic implants, surgical equipment, and neurovascular devices.
Regulatory
FDA 21 CFR Part 820
Compliant
Stryker complies with FDA Quality System Regulation (21 CFR Part 820) for medical device manufacturing, governing design controls, corrective actions, and production processes across all US-based and FDA-registered Stryker manufacturing facilities.
Regulatory
EU MDR 2017/745
Compliant
Stryker has transitioned its European medical device portfolio to comply with EU Medical Device Regulation (MDR) 2017/745, including updated clinical evaluation reports, EUDAMED registration, and post-market clinical follow-up for orthopedic and neurovascular devices.
Privacy
HIPAA
Compliant
Stryker's digital health platforms including Vocera clinical communication software and MAKO robotic surgery data systems comply with HIPAA privacy and security requirements, protecting patient health information processed in hospital and surgical environments.
Safety
ISO 14971:2019
Certified
Stryker applies ISO 14971:2019 risk management processes throughout the design and development lifecycle of all medical devices, ensuring systematic hazard identification, risk evaluation, and risk control for orthopedic implants and surgical robotics.
Safety
IEC 60601-1
Certified
Stryker's active medical electrical equipment including MAKO robotic surgery systems, surgical power tools, and patient monitoring devices comply with IEC 60601-1 safety standards governing electrical safety and essential performance for medical electrical equipment.
Security
SOC 2 Type II
Certified
Stryker's Vocera clinical communication platform and MAKO SmartRobotics cloud systems are SOC 2 Type II certified, ensuring the security, availability, and confidentiality of patient care workflow data and robotic surgery performance data stored in Stryker's cloud infrastructure.
Quality
ASTM F2033
Certified
Stryker's total joint replacement and trauma implant products are tested and certified to ASTM F2033 and related ASTM standards governing mechanical performance, biocompatibility, and corrosion resistance for metallic orthopedic implant materials.
Environmental
ISO 14001:2015
Certified
Stryker maintains ISO 14001:2015 environmental management certification at major manufacturing facilities, supporting the company's sustainability goals including a commitment to achieving carbon neutrality across its own operations and reducing single-use surgical waste.
Regulatory
FCPA Compliance
Compliant
Stryker operates a comprehensive Foreign Corrupt Practices Act (FCPA) compliance program governing its global sales force and distribution partners, following the company's 2012 FCPA settlement and subsequent implementation of enhanced anti-bribery controls in international healthcare markets.

Stryker Corporation Interview Preparation

Interview Prep
Role-specific interview questions and keywords. Select a department, then click any role to prepare.
Orthopaedics — Joint Reconstruction· 3 roles

Stryker Corporation Products & Competitors

Product Suite
5 products · select one to explore
Healthcare
Hardware
MAKO SmartRobotics
See more. Feel more. Do more.

MAKO SmartRobotics is Stryker's robotic-assisted surgical platform for total and partial knee replacement and total hip arthroplasty. It uses CT-based 3D planning, a robotic arm with haptic boundary enforcement, and real-time intraoperative data to guide surgeons in precise implant positioning and soft tissue balancing, improving alignment outcomes and reducing revision rates.

Use Cases
Using MAKO CT planning to preoperatively model a varus deformity knee and define the resection boundaries for a Stryker Triathlon total knee replacementPerforming a MAKO total hip arthroplasty with real-time leg length and offset adjustments guided by the robotic arm before final acetabular cup impactionOnboarding a new hospital to MAKO SmartRobotics by commissioning the system, training the OR team, and proctoring the first five robotic cases
No image
Key Customers
HSS
Hospital for Special Surgery
ROI
Rothman Orthopaedic Institute
CS
Cedars-Sinai Medical Center
Competitive Intelligence
VSVELYS Robotic-Assisted Solution (J&J)
THEM

VELYS is J&J MedTech's robotic-assisted solution for total knee arthroplasty, designed to work exclusively with the ATTUNE Knee System, using intraoperative bone registration without a pre-operative CT scan to guide implant positioning and soft tissue balance.

EDGE

MAKO's CT-based 3D preoperative planning enables surgeon preparation before entering the OR, supporting both knee and hip procedures on one platform

VSRosa Knee (Zimmer Biomet)
THEM

Rosa Knee is Zimmer Biomet's robotic surgical assistant for total knee arthroplasty, offering optional CT or X-ray based planning with an open platform approach compatible with multiple implant systems and surgical approaches.

EDGE

MAKO has the world's largest robotic orthopedic surgery installed base with 2M+ procedures, providing unmatched outcome data and surgeon training ecosystem

VSNavio (Smith+Nephew)
THEM

Navio is Smith+Nephew's image-free robotic-assisted surgery system for partial and total knee replacement, using handheld burr technology and real-time 3D mapping without a pre-operative CT scan.

EDGE

MAKO's haptic boundary enforcement technology provides active robotic arm control rather than passive guidance, ensuring the surgeon cannot inadvertently cut outside the planned resection zone

Related Companies

Eli Lilly logo
Eli Lilly
Healthcare
Eli Lilly is a global pharmaceutical company that discovers, develops, and markets medicines across diabetes, oncology, immunology, and neuroscience. Its GLP-1 receptor agonist portfolio — Mounjaro (tirzepatide) for type 2 diabetes and Zepbound for obesity — drove record revenue growth and positioned Lilly as one of the world's most valuable pharmaceutical companies.
Agilent Technologies logo
Agilent Technologies
Healthcare
Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical analysis, providing instruments, software, services, and consumables for laboratories worldwide. Its customers include pharmaceutical companies, academic research institutions, environmental labs, and food safety organizations that rely on Agilent's measurement science for analysis, testing, and compliance workflows.
Abbott Laboratories logo
Abbott Laboratories
Healthcare
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals. Its portfolio spans the FreeStyle Libre continuous glucose monitoring system — the world's most-used CGM — alongside cardiac devices, point-of-care diagnostics, and infant nutrition brands across 160 countries.
Thermo Fisher Scientific logo
Thermo Fisher Scientific
Healthcare
Thermo Fisher Scientific is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services for scientific research, bioprocessing, clinical diagnostics, and pharmaceutical manufacturing. With over $44B in annual revenue, Thermo Fisher serves pharmaceutical and biotech companies, academic research institutions, clinical laboratories, and government agencies with an unmatched portfolio spanning mass spectrometry, chromatography, cell culture, genetic analysis, and laboratory equipment.
Medtronic logo
Medtronic
Healthcare
Medtronic is the world's largest standalone medical device company, developing therapies and diagnostics across cardiac rhythm management, surgical robotics, neuromodulation, diabetes technology, and endoscopy. Its portfolio spans implantable cardiac monitors, transcatheter pacemakers, robotic surgery platforms, and closed-loop insulin delivery systems used in over 150 countries.
Johnson & Johnson logo
Johnson & Johnson
Healthcare
Johnson & Johnson is one of the world's largest healthcare companies, operating across two segments — Innovative Medicine, which develops and markets prescription pharmaceuticals for oncology, immunology, neuroscience, and cardiovascular diseases, and MedTech, which produces surgical robotics, orthopedics, cardiovascular devices, and vision care products. After spinning off its consumer health division as Kenvue in 2023, J&J focuses exclusively on innovative medicine and medical technology.